Hard to believe?, page-33

Here’s an article on a new miracle cure for cancer using a Toxic Drug attached to a MAB. The writer finds it very exciting. It appears to bring the cancer into remission for up to nine months. However it does have considerable side affects. This really does highlight how good IMU’s approach really is.

My view is that IMU will pick up a deal with a major much earlier than is the norm. With precision medicine such as Her-Van, I don’t believe such larger numbers of patients is as critical to sign a deal. Because they have such good knowledge of the method of action. Including substantial and repeatable laboratory evidence.

Also considering the wide scope of this drug , the sooner big pharma are involved, the sooner multiple trials can begin. The patent clock is always ticking.

https://www.technologynetworks.com/...IGlmNQV10IuACAzeRTPpRO7aN9L5Ed_PDQl4ioBnBxnto